Fabio Taborre suspended for adverse analytical finding of EPO-stimulating drug

Androni Giocattoli-Sidermec faces suspension for second failed test in 2015

The UCI has notified Fabio Taborre (Androni Giocattoli-Sidermec) of an adverse analytical finding of FG-4592, a prohibited substance that stimulates the endogenous production of EPO, in a sample collected during an out-of-competition test on June 16, 2015.

Taborre has the right to request and attend the analysis of the B sample, but has been provisionally suspended until the adjudication of the matter.

Taborre’s failed test constitutes the second adverse analytical finding for an Androni Giocattoli-Sidermec rider since the beginning of 2015—Davide Appollonio was suspended for EPO in June. In accordance with new UCI rules, the team therefore faces a suspension of between 15 and 45 days. The UCI will refer the matter to its Disciplinary Commission, which will render a decision in the upcoming days.